Literature DB >> 22728293

Early relaparotomy after simultaneous pancreas-kidney transplantation.

Mathieu Page1, Thomas Rimmelé, Charles-Eric Ber, Françoise Christin, Lionel Badet, Emmanuel Morelon, René Ecochard, Bernard Allaouchiche.   

Abstract

BACKGROUND: Simultaneous pancreas-kidney transplantation (SPKT) is a promising therapy for type 1 diabetes mellitus with chronic kidney disease. Although the long-term outcome of SPKT is extensively documented, the incidence of early complications within the first weeks after the surgery is less described. The aim of this study was to assess the incidence, causes, and risk factors of early relaparotomy after SPKT.
METHODS: All SPKT performed in the university hospital between 2005 and 2008 were enrolled. The primary endpoint was defined as the need for at least one relaparotomy after SPKT within the initial hospital stay. The secondary endpoints were the incidence of vascular graft thrombosis, postoperative sepsis, patient, and graft survival.
RESULTS: Sixty-one patients were included. During their initial hospital stay, 27 (44.3%) SPKT recipients required at least one relaparotomy. The main causes of relaparotomy were hemorrhage (59.3%) and vascular graft thrombosis (22.2%). First relaparotomy occurred at a median postoperative time of 1 day (interquartile range, 1-6). Pretransplant dialysis and nontraumatic cause of donor brain death were identified as independent risk factors for early relaparotomy. Thirty-two patients (52.4%) experienced a symptomatic or asymptomatic vascular graft thrombosis.
CONCLUSIONS: The early postoperative period remains a high-risk phase for relaparotomy. The selection of recipients before initiation of long-term dialysis and of donors deceased from traumatic causes may reduce the rate of these early complications after SPKT. Vascular graft thrombosis and bleeding are two major issues that arise during this critical period, suggesting the importance an adequate management of postoperative anticoagulation and hemostasis.

Entities:  

Mesh:

Year:  2012        PMID: 22728293     DOI: 10.1097/TP.0b013e318254dae1

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  4 in total

1.  Ex situ Perfusion of Pancreas for Whole-Organ Transplantation: Is it Safe and Feasible? A Systematic Review.

Authors:  Thomas Prudhomme; Delphine Kervella; Stéphanie Le Bas-Bernardet; Diego Cantarovich; Georges Karam; Gilles Blancho; Julien Branchereau
Journal:  J Diabetes Sci Technol       Date:  2019-08-13

2.  Use of Ex Vivo Normothermic Perfusion for Quality Assessment of Discarded Human Donor Pancreases.

Authors:  A D Barlow; M O Hamed; D H Mallon; R J Brais; F M Gribble; M A Scott; W J Howat; J A Bradley; E M Bolton; G J Pettigrew; S A Hosgood; M L Nicholson; K Saeb-Parsy
Journal:  Am J Transplant       Date:  2015-05-18       Impact factor: 8.086

3.  Simultaneous pancreas-kidney transplantation: lessons learned from the initial experience of a single center in Korea.

Authors:  Suh Min Kim; Woo Young Youn; Doo Jin Kim; Joo Seop Kim; Samuel Lee
Journal:  Ann Surg Treat Res       Date:  2014-12-26       Impact factor: 1.859

4.  Risk Factors for Early Pancreatic Allograft Thrombosis Following Simultaneous Pancreas-Kidney Transplantation: A Systematic Review.

Authors:  Jian Blundell; Sara Shahrestani; Rebecca Lendzion; Henry J Pleass; Wayne J Hawthorne
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.